Table 5.
Sr. No. | Ligand | Score | Interacting Residues | Bond Type | Bond Distance |
---|---|---|---|---|---|
1 | Niacin | −14.7132 | MET 103 | HB | 1.84 |
ASP 104 | HB | 2.07 | |||
2 | Thiamine | −13.5476 | PHE 102 | Pi-Pi Stacking | 4.92 |
SER 383 | HB | 1.81 | |||
SER 123 | HB | 1.69 | |||
3 | Ascorbic acid | −11.9942 | ASP 163 | HB | 2.30 |
TRP 356 | HB | 1.70 | |||
CYS 386 | HB | 1.86 | |||
SER 199 | HB | 2.44 | |||
ALA 162 | HB | 2.12 | |||
4 | Riboflavin | −9.4202 | PHE 170 | Pi-Pi Stacking | 5.43 |
MET 103 | HB | 1.96 | |||
SER 383 | HB | 2.06 | |||
5 | 8 nonynoic acid | −4.3902 | ASP 104 | HB | 1.84 |
6 | 9 Decynoic acid | −3.8828 | ASP 104 | HB | 1.95 |
MET 103 | HB | 1.83 | |||
7 | Methyl 8-oxooctadec-9-ynoate | −3.0906 | ASN 389 | HB | 2.66 |
TRP 356 | HB | 1.86 | |||
8 | Methyl non-8-ynoate | −2.5398 | TRP 356 | HB | 1.95 |
9 | Methyl Dec-9-ynoate | −2.4934 | TRP 356 | HB | 1.95 |
10 | (9) Methyl (E)-11-methoxy-9-oxononadec-10-enoate | −2.1673 | TRP 356 | HB | 1.95 |
11 | Quercetin 3,3′ diglucoside | −1.505 | SER 383 | HB | 2.61 |
TRP 356 | HB | 2.51 | |||
SER 390 | HB | 1.50 | |||
12 | Methyl malvalate | −0.5677 | No Interaction | ||
13 | Methyl Sterculate | −0.2554 | ASN 389 | HB | 2.50 |
TRP 356 | HB | 1.85 | |||
14 | Quercetin 3,4′ diglucoside | −0.201 | PHE 174 | Pi-Pi Stacking | 5.44 |
ASP 104 | HB | 2.14 | |||
15 | Campesterol | 3.5794 | No Interaction | ||
16 | Beta rosasterol | 6.6198 | |||
17 | Beta sitosterol | 6.6198 | |||
18 | Orlistat | −1.7877 | MET 103 | HB | 1.82 |
ASP 104 | HB | 2.09 | |||
SER 383 | HB | 1.65 |
Orlistat, as only standard drug used in market is used as standard reference for docking studies. Hence the docking result of orlistat in all tables is bold for ease of comparison.